In 2024, many analysts and experts anticipate an economic revival as we see lower inflation rates, solid growth and more jobs. Certainly, after a stressful past few years, such an outlook is refreshing. Several high-growth stocks have surged, becoming millionaire-maker stocks investors wish they had bought during the market’s doldrums in 2022. But that’s neither
0 Comments
Hypergrowth stocks provide some exciting opportunities for quick returns. Because growth stocks have a high-beta, opportunities are created in a correction or when the growth story faces near term headwinds. Growth stocks with weak fundamentals might take time to recover. However, fundamentally strong growth stocks are unlikely to trade at a valuation gap for an
0 Comments
Although the S&P 500 is at all-time highs, some stocks have lagged significantly. For instance, we have seen bifurcation among the Magnificent Seven, with underperformance from Tesla (NASDAQ:TSLA) and Apple (NASDAQ:AAPL). Even among the best Dow stocks, there are some laggards with favorable risk-reward profiles. But why pick the laggards? Chasing momentum might seem irresistible
0 Comments
Nvidia (NASDAQ:NVDA) has been on an absolute tear to start 2024. The company’s stock surged on Tuesday, extending its winning streak and propelling NVDA stock back toward its all-time high. The stock rose 7.2% amid a mixed market. Strong quarterly results from Oracle (NYSE:ORCL) fueled Nvidia’s climb, with demand for AI-focused cloud services driving growth.
0 Comments
Thanks to digital transformation accelerating globally, semiconductors have become indispensable in the tech supply chain. The space has grown exponentially due to surging chip demand across sectors like AI, consumer tech, telecom, automotive, and data centers. Of course, this type of growth can attract a lot of attention from investors. However, one must comb through
0 Comments
Few stock sectors offer soar-or-sink possibilities like biotechnology stocks do. If you’re in the market for an intriguing biotech pick and can manage high risk, take a look at Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)stock. Actinium Pharmaceuticals develops targeted radiotherapies for refractory cancer cases. By “refractory,” I mean that Actinium Pharmaceuticals focuses on helping patients meaningfully improve their
0 Comments
Snowflake (NYSE:SNOW), which specializes in software for cloud-based data warehousing, was recently overvalued. I tried to warn investors about Snowflake’s trailing price-to-earnings ratio and suggested that SNOW stock was vulnerable to a pullback. That pullback came to pass, but it’s still not the right time to take a share position. Sure, Snowflake as an artificial intelligence
0 Comments
Everyone might be talking about the stock performance of Nvidia (NASDAQ:NVDA) last year but Super Micro Computer (NASDAQ:SMCI) stock blew away the chipmaker. SMCI stock is up 1,200% compared to the measly tripling in value by Nvidia.  The manufacturer of servers, networks, storage solutions, workstations and more optimized for artificial intelligence (AI) has gotten an
0 Comments